In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Rise Of The Alt-Deal

Executive Summary

As the pharmaceutical industry works to manage big data, improve the way drugs are used and delivered, and expand services to patients, industry is working increasingly with non-traditional partners.

Advertisement

Related Content

Device/Diagnostics Quarterly Deal Statistics, Q3 2016
2016 Pharma Dealmaking: Waiting On The High-Value Deals
Astellas Dips Into Digital Health Via New Venture
GSK And Google To Invest £540m In UK-Headquartered Bioelectronics JV
Mylan's Generic Advair FDA Filing Puts Added Squeeze On GSK

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV004926

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel